Fusion oncogenes and tumor type specificity - Insights from salivary gland tumors

Seminars in Cancer Biology

Volumn 15, Issue 3, 2005, Pages 224-235

  Stenman, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromosome translocation; Clear cell hidradenoma; Fusion oncogene; HMGA2; MAML2; Mucoepidermoid carcinoma; PLAG1; Pleomorphic adenoma; Salivary gland tumors; Warthin's tumor

Indexed keywords

CYCLIC AMP; DNA BINDING PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAML2; TRANSCRIPTION FACTOR PLAG1; UNCLASSIFIED DRUG;

CELL CYCLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL EXAMINATION; CYTOGENETICS; DNA BINDING; GENE; GENE FUSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; LEUKEMIA; MAML2 FUSION GENE; MOLECULAR BIOLOGY; ONCOGENE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SALIVARY GLAND CARCINOMA; SALIVARY GLAND TUMOR; SARCOMA; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TORC1 FUSION GENE;

EID: 17044434576     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.01.002     Document Type: Review

References (117)

1. T.H. Rabbitts Chromosomal translocations in human cancer Nature 372 1994 143 149
2. J.D. Rowley Chromosome translocations: dangerous liaisons revisited Nat Rev Cancer 1 2001 245 250
3. J.M. Scandura, P. Boccuni, P.J. Cammenga, and S.D. Nimer Transcription factor fusions in acute leukemia: variations on a theme Oncogene 21 2002 3422 3444
4. P. Åman Fusion genes in solid tumors Semin Cancer Biol 9 1999 303 318
5. M.A. Pierotti Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma Cancer Lett 166 2001 1 7
6. G. Tallini, and S.L. Asa RET oncogene activation in papillary thyroid carcinoma Adv Anat Pathol 8 2001 345 354
7. P. Argani, and M. Ladanyi Recent advances in pediatric renal neoplasia Adv Anat Pathol 10 2003 243 260
8. I.J. Davis, B.L. Hsi, J.D. Arroyo, S.O. Vargas, Y.A. Yeh, and G. Motyckova Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation Proc Natl Acad Sci USA 100 2003 6051 6056
9. D. Bodmer, W. van den Hurk, J.J. van Groningen, M.J. Eleveld, G.J. Martens, and M.A. Weterman Understanding familial and non-familial renal cell cancer Hum Mol Genet 11 2002 2489 2498
10. C. Tognon, S.R. Knezevich, D. Huntsman, C.D. Roskelley, N. Melnyk, and J.A. Mathers Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cancer Cell 2 2002 367 376
11. M. Eguchi, M. Eguchi-Ishimae, A. Tojo, K. Morishita, K. Suzuki, and Y. Sato Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) Blood 93 1999 1355 1363
12. B.P. Rubin, C.J. Chen, T.W. Morgan, S. Xiao, H.E. Grier, and H.P. Kozakewich Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma Am J Pathol 153 1998 1451 1458
13. S.R. Knezevich, D.E. McFadden, W. Tao, J.F. Lim, and P.H. Sorensen A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Nat Genet 18 1998 184 187
14. J.P. Shah, and J.K. Ihde Salivary gland tumors Curr Probl Surg 27 1990 775 883
15. G. Seifert Histological typing of salivary gland tumours 2nd ed. 1991 Springer-Verlag Berlin
16. C.A. Waldron Mixed tumor (pleomorphic adenoma and myoepithelioma) G.L. Ellis P.L. Auclair D.R. Gnepp Surgical pathology of the salivary glands 1991 W.B. Saunders Company Philadelphia 165 184
17. G.R. Warnnock Papillary cystadenoma lymphomatosum (Warthin's tumor) G.L. Ellis P.L. Auclair D.R. Gnepp Surgical pathology of the salivary glands 1991 W.B. Saunders Company Philadelphia 187 201
18. P.L. Auclair, and G.L. Ellis Mucoepidermoid carcinoma G.L. Ellis P.L. Auclair D.R. Gnepp Surgical pathology of the salivary glands 1991 W.B. Saunders Company Philadelphia 269 298
19. A.M. Marchevsky Bronchial gland tumors M.J. Saldana Pathology of pulmonary disease 1994 Lippincott Philadelphia 597 607
20. J. Mark, R. Dahlenfors, C. Ekedahl, and G. Stenman The mixed salivary gland tumor - a normally benign human neoplasm frequently showing specific chromosome abnormalities Cancer Genet Cytogenet 2 1980 231 241
21. J. Sandros, G. Stenman, and J. Mark Cytogenetic and molecular observations in human and experimental salivary gland tumors Cancer Genet Cytogenet 44 1990 153 167
22. J. Bullerdiek, G. Wobst, K. Meyer-Bolte, R. Chilla, J. Haubrich, and B. Thode Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior Cancer Genet Cytogenet 65 1993 27 31
23. J. Mark, R. Dahlenfors, and B. Wedell Impact of the in vitro technique used on the cytogenetic patterns in pleomorphic adenomas Cancer Genet Cytogenet 95 1997 9 15
24. G. Stenman, J. Bullerdiek, S. Bartnitzke, P. Sahlin, E. Röijer, and J. Mark Specificity and implications of chromosome 12 abnormalities in pleomorphic adenomas J. Bullerdiek S. Bartnitzke Chromosome 12 aberrations in human solid tumors - cytogenetics and molecular genetics 1994 Springer-Verlag Berlin 3 15
25. J. Bullerdiek, J. Haubrich, K. Meyer, and S. Bartnitzke Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland Cancer Genet Cytogenet 35 1988 129 132
26. J. Mark, R. Dahlenfors, G. Stenman, and A. Nordkvist A human adenolymphoma showing the chromosomal aberrations del (7)(p12p14-15) and t(11;19)(q21;p12-13) Anticancer Res 9 1989 1565 1566
27. J. Mark, R. Dahlenfors, G. Stenman, and A. Nordkvist Chromosomal patterns in Warthin's tumor. A second type of human benign salivary gland neoplasm Cancer Genet Cytogenet 46 1990 35 39
28. A. Nordkvist, J. Mark, R. Dahlenfors, M. Bende, and G. Stenman Cytogenetical observations in 13 adenolymphomas (Warthin tumors) Cancer Genet Cytogenet 76 1994 129 135
29. C. Martins, I. Fonseca, L. Roque, and J. Soares Cytogenetic characterisation of Warthin's tumour Oral Oncol 33 1997 344 347
30. A. Nordkvist, H. Gustafsson, M. Juberg-Ode, and G. Stenman Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma Cancer Genet Cytogenet 74 1994 77 83
31. R. Dahlenfors, B. Wedell, H. Rundrantz, and J. Mark Translocation(11;19) (q14-21;p12) in a parotid mucoepidermoid carcinoma of a child Cancer Genet Cytogenet 79 1995 188
32. D.E. Horsman, K. Berean, and J.S. Durham Translocation (11;19)(q21;p13.1) in mucoepidermoid carcinoma of salivary gland Cancer Genet Cytogenet 80 1995 165 166
33. G. Stenman, V. Petursdottir, G. Mellgren, and J. Mark A child with a t(11;19)(q14-21;p12) in a pulmonary mucoepidermoid carcinoma Virchows Arch 433 1998 579 581
34. K. Kas, M. Voz, E. Röijer, A.-K. Åström, E. Meynen, and G. Stenman Promoter swapping between the genes for a novel zink finger protein and β-catenin in pleomorphic adenomas with t(3;8)(p21;q12) translocations Nature Genet 15 1997 170 174
35. K. Kas, M.L. Voz, K. Hensen, E. Meyen, and W.J.M. Van de Ven Transcriptional activation capacity of the novel PLAG family of zinc finger proteins J Biol Chem 273 1998 23026 23032
36. M. Peifer Beta-catenin as oncogene: the smoking gun Science 275 1997 1752 1753
37. K. Willert, and R. Nusse Beta-catenin: a key mediator of Wnt signaling Curr Opin Genet Dev 8 1998 95 102
38. M.L. Voz, A.-K. Åström, K. Kas, J. Mark, G. Stenman, and W. Van de Ven The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter Oncogene 16 1998 1409 1416
39. A.-K. Åström, M.L. Voz, K. Kas, E. Röijer, B. Wedell, and N. Mandahl Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities - identification of SII as a new fusion partner gene Cancer Res 59 1999 918 923
40. D.P. Gearing, C.J. Thut, T. VandeBos, S.D. Gimpel, P.B. Delaney, and J. King Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130 EMBO J 10 1991 2839 2848
41. H. Park, K. Baek, C. Jeon, K. Agarwal, and O. Yoo Characterization of the gene encoding the human transcriptional elongation factor TFIIS Gene 139 1994 263 267
42. D. Reines, J.W. Conaway, and R.C. Conaway The RNA polymerase II general elongation factors Trends Biochem Sci 21 1996 351 355
43. A.-K. Åström, E.S.G. d'Amore, L. Sianati, C. Panarello, C. Morerio, and J. Mark Evidence of involvement of the PLAG1 gene in lipoblastomas Int J Oncol 16 2000 1107 1110
44. M.K. Hibbard, H.P. Kozakewich, P. Dal Cin, R. Sciot, X. Tan, and S. Xiao PLAG1 fusion oncogenes in lipoblastoma Cancer Res 60 2000 4869 4872
45. F.M. Enzinger, and S.W. Weiss Soft tissue tumors 3rd ed. 1995 Mosby St. Louis p. 401-5
46. Ström AK. Studies of PLAG1 and HMGIC fusion oncogenes in human tumors. Thesis, Göteborg University, 2003.
47. A. Zatkova, J.M. Rouillard, W. Hartmann, B.J. Lamb, R. Kuick, and M. Eckart Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma Genes Chromosom Cancer 39 2004 126 137
48. S.F. Landrette, Y.-H. Kuo, K. Hensen, B. Khosrovani, P.N. Perrat, and W.J.M. Van de Ven Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11 Blood Dec 7 2004 [epub ahead of print]
49. M.L. Voz, J. Mathys, K. Hensen, H. Pendeville, I. Van Valckenborgh, and C. Van Huffel Microarray screening for target genes of the proto-oncogene PLAG1 Oncogene 23 2004 179 191
50. C.V. Braem, K. Kas, E. Meyen, M. Debiec-Rychter, W.J. Van De Ven, and M.L. Voz Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal J Biol Chem 277 2002 19673 19678
51. M.L. Voz, N.S. Agten, W.J. Van de Ven, and K. Kas PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II Cancer Res 60 2000 106 113
52. K. Hensen, I.C. Van Valckenborgh, K. Kas, W.J. Van de Ven, and M.L. Voz The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities Cancer Res 62 2002 1510 1517
53. X.D. Zhao, W.J. Yang, L. Wang, H. Kong, W.H. Ren, and M. Zhang Development of salivary gland tumors in pleomorphic adenoma gene 1 transgenic mice Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20 2003 390 395
54. A. Abdollahi, A.K. Godwin, P.D. Miller, L.A. Getts, D.C. Schultz, and T. Taguchi Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells Cancer Res 57 1997 2029 2034
55. D. Spengler, M. Villalba, A. Hoffmann, C. Pantaloni, S. Houssami, and J. Bockaert Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain EMBO J 16 1997 2814 2825
56. A. Varrault, E. Ciani, F. Apiou, B. Bilanges, A. Hoffmann, and C. Pantaloni hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer Proc Natl Acad Sci USA 95 1998 8835 8840
57. A. Abdollahi, R. Bao, and T.C. Hamilton LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein Oncogene 18 1999 6477 6487
58. J.M.W. Geurts, E.F.P.M. Schoenmakers, E. Röijer, G. Stenman, and W. Van de Ven Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland Cancer Res 57 1997 13 17
59. J.M.W. Geurts, E.F.P.M. Schoenmakers, E. Röijer, A.-K. Åström, G. Stenman, and W. Van de Ven Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas Oncogene 16 1998 865 872
60. R. Grosschedl, K. Giese, and J. Pagel HMG domain proteins: architectural elements in the assembly of nucleoprotein structures Trends Genet 10 1994 94 100
61. X. Zhou, K.F. Benson, H.R. Ashar, and K. Chada Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C Nature 376 1995 771 774
62. B. Rommel, P. Rogalla, A. Jox, C.V. Kalle, B. Kazmierczak, and J. Wolf HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells Leuk Lymphoma 26 1997 603 607
63. G.J. Gattas, B.J. Quade, R.A. Nowak, and C.C. Morton HMGIC expression in human adult and fetal tissues and in uterine leiomyomata Genes Chromosom Cancer 25 1999 316 322
64. M. Fedele, S. Battista, L. Kenyon, G. Baldassarre, V. Fidanza, and A.J. Klein-Szanto Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas Oncogene 21 2002 3190 3198
65. J.F. Schiltz, A. Rustighi, M.A. Tessari, J. Liu, P. Braghetta, and R. Sgarra Hmga2 promoter analysis in transgenic mice Biochem Biophys Res Commun 309 2003 718 723
66. R. Reeves, and M.S. Nissen The AT-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure J Biol Chem 265 1990 8573 8582
67. A.P. Wolffe Architectural transcription factors Science 264 1994 1100 1101
68. M. Ohta, H. Inoue, M.G. Cotticelli, K. Kastury, R. Baffa, and J. Palazzo The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 1996 587 597
69. R.M. Gemmill, J.D. West, F. Boldog, N. Tanaka, L.J. Robinson, and D.I. Smith The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8 Proc Natl Acad Sci USA 95 1998 9572 9577
70. E. Roulet, M.T. Armentero, G. Krey, B. Corthesy, C. Dreyer, and N. Mermod Regulation of the DNA-binding and transcriptional activities of Xenopus laevis NFI-X by a novel C-terminal domain Mol Cell Biol 15 1995 5552 5562
71. H.R. Ashar, M.S. Fejzo, A. Tkachenko, X. Zhou, J.A. Fletcher, and S. Weremowicz Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains Cell 82 1995 57 65
72. E.F. Schoenmakers, S. Wanschura, R. Mols, J. Bullerdiek, H. Van den Berghe, and W.J. Van de Ven Recurrent rearrangements in the high mobility group protein gene HMGI-C in benign mesenchymal tumours Nat Genet 10 1995 436 444
73. B. Kazmierczak, Y. Hennig, S. Wanschura, P. Rogalla, S. Bartnitzke, and W. Van de Ven Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene Cancer Res 55 1995 6038 6039
74. M.M.R. Petit, R. Mols, E.F. Schoenmakers, N. Mandahl, and W.J. Van de Ven LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family Genomics 36 1996 118 129
75. M.M. Petit, E.F. Schoenmakers, C. Huysmans, J.M. Geurts, N. Mandahl, and W.J. Van de Ven LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes Genomics 57 1999 438 441
76. E.F. Schoenmakers, C. Huysmans, and W.J. Van de Ven Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas Cancer Res 59 1999 19 23
77. K. Kurose, N. Mine, D. Doi, Y. Ota, K. Yoneyama, and H. Konishi Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma Genes Chromosom Cancer 27 2000 303 307
78. N. Mine, K. Kurose, H. Konishi, T. Araki, H. Nagai, and M. Emi Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma Jpn J Cancer Res 92 2001 135 139
79. K. Broberg, M. Zhang, B. Strombeck, M. Isaksson, M. Nilsson, and F. Mertens Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15 Int J Oncol 21 2002 321 326
80. A. Dahlen, F. Mertens, A. Rydholm, O. Brosjo, J. Wejde, and N. Mandahl Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas Mod Pathol 16 2003 1132 1140
81. J.M. Geurts, E.F. Schoenmakers, and W.J. Van de Ven Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3′-UTR of HMGIC Cancer Genet Cytogenet 95 1997 198 205
82. M. Schoenberg Fejzo, H.R. Ashar, K.S. Krauter, W.L. Powell, M.S. Rein, and S. Weremowicz Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas Genes Chromosom Cancer 17 1996 1 6
83. S. Wanschura, B. Kazmierczak, Y. Pohnke, K. Meyer-Bolte, S. Bartnitzke, and W.J. Van de Ven Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality Cancer Lett 102 1996 17 21
84. E. Röijer, K. Kas, M. Behrendt, W. Van de Ven, and G. Stenman Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement Genes Chromosom Cancer 24 1999 78 82
85. L. Borrmann, S. Wilkening, and J. Bullerdiek The expression of HMGA genes is regulated by their 3′ UTR Oncogene 20 2001 4537 4541
86. C.J. Decker, and R. Parker Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts Curr Opin Cell Biol 7 1995 386 392
87. S. Hauke, A.M. Flohr, P. Rogalla, and J. Bullerdiek Sequencing of intron 3 of HMGA2 uncovers the existence of a novel exon Genes Chromosom Cancer 34 2002 17 23
88. B. Noro, B. Licheri, R. Sgarra, A. Rustighi, M.A. Tessari, and K.Y. Chau Molecular dissection of the architectural transcription factor HMGA2 Biochemistry 42 2003 4569 4577
89. B.J. Quade, S. Weremowicz, D.M. Neskey, R. Vanni, C. Ladd, and P. Dal Cin Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15 Cancer Res 63 2003 1351 1358
90. E. Röijer, A. Nordkvist, A.K. Strom, W. Ryd, M. Behrendt, and J. Bullerdiek Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma Am J Pathol 160 2002 433 440
91. G. Reifenberger, K. Ichimura, J. Reifenberger, A.G. Elkahloun, P.S. Meltzer, and V.P. Collins Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets Cancer Res 56 1996 5141 5145
92. J.M. Berner, L.A. Meza-Zepeda, P.F. Kools, A. Forus, E.F. Schoenmakers, and W.J. Van de Ven HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas Oncogene 14 1997 2935 2941
93. L.A. Meza-Zepeda, J.M. Berner, J. Henriksen, A.P. South, F. Pedeutour, and A.B. Dahlberg Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions Genes Chromosom Cancer 31 2001 264 273
94. S. Battista, V. Fidanza, M. Fedele, A.J. Klein-Szanto, E. Outwater, and H. Brunner The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis Cancer Res 59 1999 4793 4797
95. P. Arlotta, A.K. Tai, G. Manfioletti, C. Clifford, G. Jay, and S.J. Ono Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas J Biol Chem 275 2000 14394 14400
96. P. Finelli, G.M. Pierantoni, D. Giardino, M. Losa, O. Rodeschini, and M. Fedele The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas Cancer Res 62 2002 2398 2405
97. M.A. Tessari, M. Gostissa, S. Altamura, R. Sgarra, A. Rustighi, and C. Salvagno Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 Mol Cell Biol 23 2003 9104 9116
98. L. Borrmann, R. Schwanbeck, T. Heyduk, B. Seebeck, P. Rogalla, and J. Bullerdiek High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity Nucleic Acids Res 31 2003 6841 6851
99. G. Tonon, S. Modi, L. Wu, A. Kubo, A.B. Coxon, and T. Komiya t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway Nat Genet 33 2003 208 213
100. F. Enlund, A. Behboudi, Y. Andren, C. Öberg, U. Lendahl, and J. Mark Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors Exp Cell Res 292 2004 21 28
101. L. Wu, T. Sun, K. Kobayashi, P. Gao, and J.D. Griffin Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors Mol Cell Biol 22 2002 7688 7700
102. S.E. Lin, T. Oyama, T. Nagase, K. Harigaya, and M. Kitagawa Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling J Biol Chem 277 2002 50612 50620
103. L. Wu, J.C. Aster, S.C. Blacklow, R. Lake, S. Artavanis-Tsakonas, and J.D. Griffin MAML1, a human homologue of Drosophila Mastermind, is a transcriptional co-activator for NOTCH receptors Nat Genet 26 2000 484 489
104. S. Artavanis-Tsakonas, K. Matsuno, and M.E. Fortini Notch signaling Science 268 1995 225 232
105. M.D. Conkright, G. Canettieri, R. Screaton, E. Guzman, L. Miraglia, and J.B. Hogenesch TORCs: transducers of regulated CREB activity Mol Cell 12 2003 413 423
106. V. Iourgenko, W. Zhang, C. Mickanin, I. Daly, C. Jiang, and J.M. Hexham Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells Proc Natl Acad Sci USA 100 2003 12147 12152
107. L.W. Ellisen, J. Bird, D.C. West, A.L. Soreng, T.C. Reynolds, and S.D. Smith TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms Cell 66 1991 649 661
108. C. Jhappan, D. Gallahan, C. Stahle, E. Chu, G.H. Smith, and G. Merlino Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands Genes Dev 6 1992 345 355
109. S. Weijzen, P. Rizzo, M. Braid, R. Vaishnav, S.M. Jonkheer, and A. Zlobin Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells Nat Med 8 2002 979 986
110. M. Nicolas, A. Wolfer, K. Raj, J.A. Kummer, P. Mill, and M. van Noort Notch1 functions as a tumor suppressor in mouse skin Nat Genet 33 2003 416 421
111. L. Gorunova, F. Mertens, N. Mandahl, N. Jonsson, B. Persson, and S. Heim Cytogenetic heterogeneity in a clear cell hidradenoma of the skin Cancer Genet Cytogenet 77 1994 26 32
112. Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F, et al. Clear cell hidradenoma of the skin - a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosome Cancer 2005, Feb 23 [epub].
113. The Mitelman database of chromosome aberrations in cancer is available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
114. F. Mertens, B. Johansson, M. Hoglund, and F. Mitelman Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms Cancer Res 57 1997 2765 2780
115. F. Mitelman, B. Johansson, and F. Mertens Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer Nat Genet 36 2004 331 334
116. A. Barbouti, M. Hoglund, B. Johansson, C. Lassen, P.G. Nilsson, and A. Hagemeijer A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23) Cancer Res 63 2003 1202 1206
117. M. Cividin, F. Brizard, N. Sorel, M. Renaud, F. Guilhot, and A. Brizard p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22) Leuk Res 28 2004 97 99